Magic Mushroom & Psilocybin Resources (Canada & Beyond)

Magic Mushrooms Canada has curated this psilocybin and magic mushroom resources hub to help adults find reliable, research-based information. Below you’ll find articles, clinical studies, Canadian policy pages, and videos from respected institutions to support education and harm reduction, not self-prescribing.

IMPORTANT DISCLAIMER:
We do not provide medical advice. All product information is for educational purposes only. Always consult with your medical professional before purchasing or using any psilocybin or cannabis products.

How to Use This Psilocybin Resource Hub

This page is designed as a starting point for learning about psilocybin (“magic mushrooms”): what it is, how it’s being studied, and how Canada is regulating access.

We prioritize peer-reviewed science, government guidance, and university or hospital-based research programs.

Resources are grouped by theme, with SEO questions that real people ask (e.g., “Is psilocybin legal in Canada?”) so you can turn this page into a strong FAQ + internal linking hub.

This content is educational only and does not replace professional medical, legal, or mental-health advice.

Authoritative Overviews & Canadian Context

Guidance on Magic Mushrooms

Key Questions This Section Answers

Is psilocybin/magic mushrooms legal in Canada?

What is Health Canada’s position on psilocybin?

What is the Special Access Program (SAP) for psilocybin?

Where can I find health and risk information about magic mushrooms?

Key Resources (link out to):

Health Canada – “Psilocybin and psilocin (Magic mushrooms)”
– Legal status, health risks, and summary of current therapeutic research and clinical trials in Canada.

Health Canada – Special Access Program (SAP) for Psychedelic-Assisted Psychotherapy
– Explains how clinicians can request psilocybin for serious conditions when conventional treatments fail.

BCCSU – “Psilocybin: Psychedelics at a Glance”
– Evidence-based overview of effects, risks, and harm-reduction guidance from the BC Centre on Substance Use.

Scientific & Clinical Research on Psilocybin

Systematic Reviews & Mechanisms

Key Questions This Section Answers

What conditions is psilocybin being studied for?

How might psilocybin affect the brain and neuroplasticity?

What does the overall body of evidence say so far?

Core resources for high-level summaries and mechanisms of action:

“Psilocybin for Clinical Indications: A Scoping Review” (2024) – Synthesizes clinical evidence across conditions (depression, anxiety, substance use).

“Neuroplasticity and Psychedelics: A Comprehensive Examination” (2024 preprint) – Explores how psychedelics, including psilocybin, may affect brain plasticity.

Clinical Trials for Depression, Anxiety &
Cancer-Related Distress

Key Questions This Section Answers

What does clinical evidence say about psilocybin and depression?

How has psilocybin been studied in people with cancer-related anxiety or end-of-life distress?

Why must psilocybin be administered in controlled, supervised settings?

Representative resources:

Johns Hopkins – “Psychedelics Research and Psilocybin Therapy” – Overview of their trials on depression, addiction and existential distress in tightly controlled settings.

Griffiths et al. (J Psychopharmacol 2016) – High-dose psilocybin sessions reduced depressed mood/anxiety and improved quality of life in patients with life-threatening cancer.

NYU Langone Cancer Anxiety Study + Video – Single-dose psilocybin with psychotherapy for advanced cancer-related anxiety/depression; includes an explainer video.

UCHealth – “Can psilocybin help patients with advanced cancer?” (2025) – Describes one of the largest ongoing psilocybin trials for cancer patients’ mood and anxiety.

JAMA Network Open – UW Burnout & Depression Trial in Frontline Clinicians (2024) – Psilocybin-assisted therapy vs placebo for healthcare workers dealing with depression and burnout.

Canadian Research Programs &
Real-World Experience

Key Questions This Section Answers

What psilocybin studies are currently underway in Canada?

How have Canadians accessed psilocybin legally in recent years (e.g., Section 56, SAP)?

How do Canadian clinicians and pharmacists view psilocybin?

These pieces help answer Canada-specific questions: “What psilocybin research is happening in Canada?”

CIHR / University of Calgary – Parker Research Chair in Psychedelics – Overview of three psilocybin trials supported by CIHR in psychotherapy contexts.

Scientific Reports (Nature) – Longitudinal Experiences of Canadians Receiving Legal Psilocybin-Assisted Psychotherapy – Prospective survey following Canadians granted Section 56 exemptions.

“Psilocybin Therapy in Canada: What to Know” (Field Trip Health) – Summarizes the evolving research, legal status and SAP context from a clinical provider’s perspective.

“Psilocybin Therapy in Canada – What to Know” (First Session) – Consumer-facing explainer on legal status, clinics and evidence.

“Pharmacists’ Perspectives on Psilocybin in Canada” (2024) – Survey of Canadian pharmacists’ views on psilocybin as an emerging therapeutic option.

Key Questions This Section Answers

What do unregulated psilocybin dispensaries typically claim online?

Why do researchers warn about unverified medical claims and product quality in this space?

Legal Access, Dispensaries & Policy Landscape

Regulated Access Pathways in Canada

Health Canada – SAP Psilocybin/MDMA Class Exemption Notice – Explains the 2022 change that allowed requests for restricted drugs under SAP.

TheraPsil – “Patients Considering Psychedelic-Assisted Therapy” – Advocacy and education on how certain Canadians have sought legal access under existing frameworks.

Key Questions This Section Answers

How can a Canadian potentially access psilocybin legally under medical supervision?

What is the difference between clinical trials, SAP requests, and unregulated retail?

Unregulated Dispensaries & Online Health Claims

JAMA Network Open – “Psilocybin Dispensaries and Online Health Claims in Canada” (2025) – Cross-sectional study of online dispensaries, product types, and the kinds of health claims being made.

Organizations & Research Centres

Key Questions This Section Answers

Which institutions are leading psilocybin research globally?

Where can people learn more about joining legitimate clinical trials, not informal experiments?

Major International Research Centres

Johns Hopkins Center for Psychedelic & Consciousness Research – Leading clinical and mechanistic research on psilocybin.

NYU Langone Psychedelic Medicine Research Program – Includes psilocybin trials for depression, cancer distress and other indications, plus “Participate in a Clinical Trial” portal.

Canadian-Relevant Organizations & Clinics

Field Trip / Other Canadian Clinics (info pages only) – Overviews of how psychedelic-assisted therapies are being researched and piloted in Canada.

Videos, Talks & Documentaries

Science & Mechanisms

A foundational talk on why psilocybin is being revisited as a potential therapeutic tool.

Discusses emerging microdosing research and the gap between hype and data.

Depression, Anxiety & End-of-Life Care

Based on Imperial College psilocybin for depression trials

Ground-level perspective from a long-time session guide at Johns Hopkins.

Discusses emerging microdosing research and the gap between hype and data.

Ethics, Policy & Clinical Integration

Key Questions This Section Answers

What do leading researchers and clinicians say about psilocybin?

How are psilocybin trials being conducted and supervised in practice?
What ethical questions are being raised about commercialization and access?

Local & Canadian-Focused Resource Highlights

Key Questions This Section Answers

Where can I read about psilocybin in a specifically Canadian context?

What Canadian institutions are publishing data on psilocybin-assisted psychotherapy?

Canada-Specific Articles & Summaries

Health Canada psilocybin page and SAP updates. (Government of Canada)

BCCSU psilocybin sheet for harm-reduction framing. (BCCSU)

Canadian scoping reviews, Section 56 experience surveys and CIHR-funded trial summaries. (PMC)

Consumer-facing explainers from reputable Canadian clinics and directories (Field Trip, First Session, etc.). (Field Trip Health)

mmc.

mmc.

Getting all of the Nutrients you need simply cannot be done without supplements.

+1 599 162 4545

suxnix@gmail.com

Magic Mushroom & Psilocybin Resources (Canada & Beyond)

How to Use This Psilocybin Resource Hub